Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

Biotechnology

Healthcare
$9.12 +0.00%

+$0.00 today

Market cap
$605.45M
Beta
-0.53
P/E (TTM)
-8.8
EPS (TTM)
-$2.59
52W Low $8.48High $24.25

Volume 0.84M

Average 0.54M

Price history

Bicara Therapeutics Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-43.63%

Period high

$30.40

Period low

$7.93

Latest

$9.12

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
S-8Nov 10, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
SC 13G/AOct 7, 2026Oct 7, 2026
4Sep 10, 2026Sep 10, 2026
144Sep 8, 2026Sep 8, 2026
144Sep 8, 2026Sep 8, 2026
8-KAug 25, 2026Aug 25, 2026
3Aug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
4Aug 12, 2026Aug 12, 2026
4Aug 12, 2026Aug 12, 2026
4Aug 12, 2026Aug 12, 2026
8-KAug 11, 2026Aug 11, 2026

Competitors

Who does Bicara Therapeutics Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BCAX's filings, answered from its disclosures.

What is the latest BCAX filing?

The latest filing shown is S-8 dated Nov 10, 2026.

How many recent filings does BCAX have?

Intrinsic Alpha currently shows 20 recent filings for BCAX.